Article
Version 1
Preserved in Portico This version is not peer-reviewed
Risk and Prognostic Factors for Glaucoma Associated with Peters Anomaly
Version 1
: Received: 24 August 2023 / Approved: 24 August 2023 / Online: 24 August 2023 (14:33:33 CEST)
A peer-reviewed article of this Preprint also exists.
Yokota, C.; Hirooka, K.; Okada, N.; Kiuchi, Y. Risk and Prognostic Factors for Glaucoma Associated with Peters Anomaly. J. Clin. Med. 2023, 12, 6238. Yokota, C.; Hirooka, K.; Okada, N.; Kiuchi, Y. Risk and Prognostic Factors for Glaucoma Associated with Peters Anomaly. J. Clin. Med. 2023, 12, 6238.
Abstract
Glaucoma secondary to Peters' anomaly (PA) is an important factor affecting visual prognosis, but there are few reports on it. This study aimed to investigate the characteristics of glaucoma asso-ciated with PA and glaucoma surgery outcomes. This retrospective study included 31 eyes of 20 patients with PA. PA was classified into three stages: Stage 1, with a posterior corneal defect only; Stage 2, a corneal defect with iridocorneal adhesion; and Stage 3, a corneal defect with lens ab-normalities. The associations between glaucoma and anterior segment dysgenesis severity, visual prognosis, and glaucoma surgery outcomes were analyzed. Sixteen eyes of 10 patients developed glaucoma. Stage 1 PA had no glaucoma, 52% of Stage 2 had glaucoma, and 75% of Stage 3 had glaucoma. Of the 16 eyes with glaucoma, 11 underwent surgery. Eight of these 11 eyes achieved intraocular pressure (IOP) control. Five of the nine eyes that underwent trabeculotomy (TLO) succeeded, and none had corneal staphyloma. Three of the four eyes for which TLO was ineffective had corneal staphyloma (P=0.0331). Patients with PA are more likely to develop glaucoma as anterior segment dysgenesis progresses, and the effect of TLO is limited if corneal staphyloma is present.
Keywords
Peters anomaly; glaucoma; anterior segment dysgenesis; corneal staphyloma
Subject
Medicine and Pharmacology, Ophthalmology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment